<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38398460</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Navigating the Spectrum of Two Pediatric COVID-19 Complications: Multi-System Inflammatory Syndrome in Children and Post-Acute Sequelae of SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1147</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13041147</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This review summarizes the current scope of understanding associated with two common post-infectious complications associated with COVID-19 infection: Multi-System Inflammatory Syndrome in Children (MIS-C) and Post-Acute Sequelae of SARS-CoV-2 infection (PASC). It identifies current gaps in the knowledge and issues that may limit the ability to fill these gaps. This review provides a framework to drive continued research.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive review of the current literature was performed, identifying seminal articles describing the emergence of MIS-C and PASC, and works from the literature focused on the clinical implications and pathophysiologic understanding of these disorders.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Although pediatric patients experienced few severe cases of acute COVID-19 infection, the burden of disease from post-infectious sequelae is substantial. Mortality is low, but morbidity is significant. There are still numerous unknowns about the pathophysiology of both MIS-C and PASC; however, with widespread immunity developing after increased vaccination and prior infection, it may be difficult to perform adequate prospective studies to answer pathophysiologic questions. Long-term sequalae of MIS-C seem to be minimal whereas, by definition, PASC is an ongoing problem and may be severe.</AbstractText><AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">The rapid sharing of information regarding novel conditions such as MIS-C and PASC are key to interventions related to future post-infectious sequelae outside of those stemming from COVID-19. Although MIS-C seems unlikely to return as a clinical condition in substantial numbers, there is still significant learning that can be gleaned from existing patients about general aspects of epidemiology, equity, and pathophysiology. There is significant morbidity associated with PASC and additional resources need to be dedicated to determining appropriate and effective therapies moving forward.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parzen-Johnson</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4057-862X</Identifier><AffiliationInfo><Affiliation>Section of Infectious Diseases, Biological Sciences Division, University of Chicago, 5841 South Maryland Avenue, MC 6082, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Ben Z</ForeName><Initials>BZ</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, 225 E Chicago Avenue, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">MISC</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">PIM</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>Parzen-Johnson has indicated he has no conflicts of interest relevant to this article to disclose. Katz is the recipient of a supplemental award from the National Institute of Neurological Disorders and Stroke (R01 NS111105) to study Long COVID in adolescents and young adults and compare them to young adults who developed ME/CFS following mono.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38398460</ArticleId><ArticleId IdType="pmc">PMC10889837</ArticleId><ArticleId IdType="doi">10.3390/jcm13041147</ArticleId><ArticleId IdType="pii">jcm13041147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin B., DeWitt P.E., Russell S., Anand A., Bradwell K.R., Bremer C., Gabriel D., Girvin A.T., Hajagos J.G., McMurry J.A., et al. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative. JAMA Netw. Open. 2022;5:e2143151. doi: 10.1001/jamanetworkopen.2021.43151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.43151</ArticleId><ArticleId IdType="pmc">PMC8826172</ArticleId><ArticleId IdType="pubmed">35133437</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella L.A., Rowley A.H. Current Insights into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr. Pediatr. Rep. 2021;9:83&#x2013;92. doi: 10.1007/s40124-021-00257-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-021-00257-6</ArticleId><ArticleId IdType="pmc">PMC8524214</ArticleId><ArticleId IdType="pubmed">34692237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K., Castagnoli R., Vakkilainen S., Liu C., Delmonte O.M., Oguz C., Kaplan I.M., Alehashemi S., Burbelo P.D., Bhuyan F., et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 2022;28:1050&#x2013;1062. doi: 10.1038/s41591-022-01724-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01724-3</ArticleId><ArticleId IdType="pmc">PMC9119950</ArticleId><ArticleId IdType="pubmed">35177862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D., Le Pen J., Yatim A., Dong B., Aquino Y., Ogishi M., Pescarmona R., Talouarn E., Rinchai D., Zhang P., et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science. 2023;379:eabo3627. doi: 10.1126/science.abo3627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo3627</ArticleId><ArticleId IdType="pmc">PMC10451000</ArticleId><ArticleId IdType="pubmed">36538032</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., Rodriguez L., Tan Z., Zicari S., Ruggiero A., Pascucci G.R., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell. 2020;183:968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley A.H. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features. J. Pediatr. 2020;224:129&#x2013;132. doi: 10.1016/j.jpeds.2020.06.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.06.057</ArticleId><ArticleId IdType="pmc">PMC7308002</ArticleId><ArticleId IdType="pubmed">32585239</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein L.R., Tenforde M.W., Friedman K.G., Newhams M., Rose E.B., Dapul H., Soma V.L., Maddux A.B., Mourani P.M., Bowens C., et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA. 2021;325:1074&#x2013;1087. doi: 10.1001/jama.2021.2091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2091</ArticleId><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  . Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (mis-C) CDC; Atlanta, GA, USA: 2023.  [(accessed on 1 August 2023)].  Available online:  https://www.cdc.gov/mis/mis-c/hcp/index.html.</Citation></Reference><Reference><Citation>WHO  . Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19: Scientific Brief. WHO; Geneva, Switzerland: 2020.  [(accessed on 1 August 2023)].  Available online:  https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.</Citation></Reference><Reference><Citation>Aronoff S.C., Hall A., Del Vecchio M.T. The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review. J. Pediatr. Infect. Dis. Soc. 2020;9:746&#x2013;751. doi: 10.1093/jpids/piaa112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piaa112</ArticleId><ArticleId IdType="pmc">PMC7797745</ArticleId><ArticleId IdType="pubmed">32924059</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRovere K.L., Riggs B.J., Poussaint T.Y., Young C.C., Newhams M.M., Maamari M., Walker T.C., Singh A.R., Dapul H., Hobbs C.V., et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;78:536&#x2013;547. doi: 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccotti G., Calcaterra V., Mannarino S., D&#x2019;auria E., Bova S.M., Fiori L., Verduci E., Milanese A., Marano G., Garbin M., et al. Six-month multidisciplinary follow-up in multisystem inflammatory syndrome in children: An Italian single-center experience. Front. Pediatr. 2022;10:1080654. doi: 10.3389/fped.2022.1080654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.1080654</ArticleId><ArticleId IdType="pmc">PMC9909209</ArticleId><ArticleId IdType="pubmed">36776681</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., Auriau J., M&#xe9;ot M., Oualha M., Renolleau S., Houyel L., Bonnet D. Addition of Corticosteroids to Immunoglobulins Is Associated with Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children. Circulation. 2020;142:2282&#x2013;2284. doi: 10.1161/CIRCULATIONAHA.120.050147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050147</ArticleId><ArticleId IdType="pmc">PMC7717473</ArticleId><ArticleId IdType="pubmed">33112651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N., Toubiana J., Antona D., Javouhey E., Madhi F., Lorrot M., L&#xe9;ger P.-L., Galeotti C., Claude C., Wiedemann A., et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone with Course of Fever in Multisystem Inflammatory Syndrome in Children. JAMA. 2021;325:855&#x2013;864. doi: 10.1001/jama.2021.0694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.0694</ArticleId><ArticleId IdType="pmc">PMC7851757</ArticleId><ArticleId IdType="pubmed">33523115</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M.B.F., Murray N., Friedman K., Young C.C., Newhams M.M., Feldstein L.R., Loftis L.L., Tarquinio K.M., Singh A.R., Heidemann S.M., et al. Multisystem Inflammatory Syndrome in Children&#x2014;Initial Therapy and Outcomes. N. Engl. J. Med. 2021;385:23&#x2013;34. doi: 10.1056/NEJMoa2102605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102605</ArticleId><ArticleId IdType="pmc">PMC8220972</ArticleId><ArticleId IdType="pubmed">34133855</ArticleId></ArticleIdList></Reference><Reference><Citation>McArdle A.J., Vito O., Patel H., Seaby E.G., Shah P., Wilson C., Broderick C., Nijman R., Tremoulet A.H., Munblit D., et al. Treatment of Multisystem Inflammatory Syndrome in Children. N. Engl. J. Med. 2021;385:11&#x2013;22. doi: 10.1056/NEJMoa2102968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2102968</ArticleId><ArticleId IdType="pmc">PMC8220965</ArticleId><ArticleId IdType="pubmed">34133854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N., Son M.B.F., McArdle A.J., Vito O., Vaugon E., Belot A., Leblanc C., Murray N.L., Patel M.M., Levin M., et al. Immunomodulatory Therapy for MIS-C. Pediatrics. 2023;152:e2022061173. doi: 10.1542/peds.2022-061173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-061173</ArticleId><ArticleId IdType="pubmed">37376963</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBiasi R.L. Immunotherapy for MIS-C&#x2014;IVIG, Glucocorticoids, and Biologics. N. Engl. J. Med. 2021;385:74&#x2013;75. doi: 10.1056/NEJMe2108276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2108276</ArticleId><ArticleId IdType="pmc">PMC8362545</ArticleId><ArticleId IdType="pubmed">34133878</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dove M.L., Jaggi P., Kelleman M., Abuali M., Ang J.Y., Ballan W., Basu S.K., Campbell M.J., Chikkabyrappa S.M., Choueiter N.F., et al. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. J. Pediatr. 2021;229:33&#x2013;40. doi: 10.1016/j.jpeds.2020.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.10.026</ArticleId><ArticleId IdType="pmc">PMC7566788</ArticleId><ArticleId IdType="pubmed">33075369</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  . Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States. CDC; Atlanta, GA, USA: 2021.  [(accessed on 11 August 2023)].  Available online:  https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.</Citation></Reference><Reference><Citation>Abrams J.Y., Godfred-Cato S.E., Oster M.E., Chow E.J., Koumans E.H., Bryant B., Leung J.W., Belay E.D. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review. J. Pediatr. 2020;226:45&#x2013;54.e1. doi: 10.1016/j.jpeds.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7403869</ArticleId><ArticleId IdType="pubmed">32768466</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne A.B., Gilani Z., Godfred-Cato S., Belay E.D., Feldstein L.R., Patel M.M., Randolph A.G., Newhams M., Thomas D., Magleby R., et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw. Open. 2021;4:e2116420. doi: 10.1001/jamanetworkopen.2021.16420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16420</ArticleId><ArticleId IdType="pmc">PMC8193431</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N., Koppel J.H., Kaplan O., Yechiam H., Shahar-Nissan K., Cohen N.K., Shavit I. Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel. JAMA. 2022;327:2452&#x2013;2454. doi: 10.1001/jama.2022.8025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8025</ArticleId><ArticleId IdType="pmc">PMC9121298</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.M., Carter M.J., Cheung C.R., Ladhani S. Lower Risk of Multisystem Inflammatory Syndrome in Children with the Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2. Clin. Infect. Dis. 2023;76:e518&#x2013;e521. doi: 10.1093/cid/ciac553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac553</ArticleId><ArticleId IdType="pmc">PMC9278259</ArticleId><ArticleId IdType="pubmed">35788276</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm M., Espenhain L., Glenth&#xf8;j J., Schmidt L.S., Nordly S.B., Hartling U.B., Nygaard U. Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. JAMA Pediatr. 2022;176:821&#x2013;823. doi: 10.1001/jamapediatrics.2022.2206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2206</ArticleId><ArticleId IdType="pmc">PMC9178498</ArticleId><ArticleId IdType="pubmed">35675054</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Allin B., Nugawela M.D., Rojas N., Dalrymple E., Pereira S.P., Soni M., Knight M., Cheung E.Y., Heyman I., et al. Long COVID (post-COVID-19 condition) in children: A modified Delphi process. Arch. Dis. Child. 2022;107:674&#x2013;680. doi: 10.1136/archdischild-2021-323624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D.S., Rea T.D., Katon W.J., Russo J.E., Ashley R.L. Acute infectious mononucleosis: Characteristics of patients who report failure to recover. Am. J. Med. 2000;109:531&#x2013;537. doi: 10.1016/S0002-9343(00)00560-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(00)00560-X</ArticleId><ArticleId IdType="pubmed">11063953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., Reeves W.C., Lloyd A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz B.Z., Shiraishi Y., Mears C.J., Binns H.J., Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124:189&#x2013;193. doi: 10.1542/peds.2008-1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P.Y., Ma J., Kim Y.-C., Son A.Y., Syed A.M., Liu C., Mori M.P., Huffstutler R.D., Stolinski J.L., Talagala S.L., et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2023;120:e2302738120. doi: 10.1073/pnas.2302738120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2302738120</ArticleId><ArticleId IdType="pmc">PMC10450651</ArticleId><ArticleId IdType="pubmed">37579159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique L.A., Jakabek D., Bracken S.G., Allen-Davidian Y., Heng B., Chow S., Dehhaghi M., Pires A.S., Darley D.R., Byrne A., et al. The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC. Ann. Clin. Transl. Neurol. 2023;10:1338&#x2013;1352. doi: 10.1002/acn3.51825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51825</ArticleId><ArticleId IdType="pmc">PMC10424655</ArticleId><ArticleId IdType="pubmed">37318955</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Appelman B., Mooij-Kalverda K., Houtkooper R.H., van Weeghel M., Vaz F.M., Dijkhuis A., Dekker T., Smids B.S., Duitman J.W., et al. Prolonged indoleamine 2,3-dioxygenase-2 activity and associated cellular stress in post-acute sequelae of SARS-CoV-2 infection. EBioMedicine. 2023;94:104729. doi: 10.1016/j.ebiom.2023.104729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104729</ArticleId><ArticleId IdType="pmc">PMC10406961</ArticleId><ArticleId IdType="pubmed">37506544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv. 2021 doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J., Reincke S.M., Kornau H.-C., S&#xe1;nchez-Sendin E., Corman V.M., Liu H., Yuan M., Wu N.C., Zhu X., Lee C.-C.D., et al. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020;183:1058&#x2013;1069.e19. doi: 10.1016/j.cell.2020.09.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.049</ArticleId><ArticleId IdType="pmc">PMC7510528</ArticleId><ArticleId IdType="pubmed">33058755</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Beliz&#xe1;rio J.E., Faintuch J. Microbiome and Gut Dysbiosis. Exp. Suppl. 2018;109:459&#x2013;476. doi: 10.1007/978-3-319-74932-7_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-74932-7_13</ArticleId><ArticleId IdType="pubmed">30535609</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-2022, 6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi I., Goessler K., J&#xfa;nior G.N.d.O., Prado D.M.L.D., Santos J.V.P., Meletti M.M., de Andrade D.C.O., Gil S., Boza J.A.S.d.O., Lima F.R., et al. Effects of a 16-week home-based exercise training programme on health-related quality of life, functional capacity, and persistent symptoms in survivors of severe/critical COVID-19: A randomised controlled trial. Br. J. Sports Med. 2023;57:1295&#x2013;1303. doi: 10.1136/bjsports-2022-106681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2022-106681</ArticleId><ArticleId IdType="pubmed">37164620</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S., Zhang A., O&#x2019;Mahoney L., Stephenson T., Ladhani S., De Stavola B., Viner R., Swann O. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink T.T., Marques H.H., Gualano B., Lindoso L., Bain V., Astley C., Martins F., Matheus D., Matsuo O.M., Suguita P., et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital. Clinics. 2021;76:e3511. doi: 10.6061/clinics/2021/e3511.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e3511</ArticleId><ArticleId IdType="pmc">PMC8595593</ArticleId><ArticleId IdType="pubmed">34852145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and Persistent Symptoms in Children with Polymerase Chain Reaction (PCR)-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Compared With Test-Negative Children in England: Active, Prospective, National Surveillance. Clin. Infect. Dis. 2022;75:e191&#x2013;e200. doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pereira S.M.P., Shafran R., de Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;Mahoney L., Chalder T., et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child. Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L., Bull-Otterson L., Boehmer T.K., Baca S., Alvarez P., Hong K., Hsu J., Harris A.M., Gundlapalli A.V., Saydah S. Post-COVID-19 Symptoms and Conditions Among Children and Adolescents&#x2014;United States, 1 March 2020&#x2013;31 January 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:993&#x2013;999. doi: 10.15585/mmwr.mm7131a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7131a3</ArticleId><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky J.R., Tao G., Lavery A.M., A Kukielka E., Click E.S., Malec D., Kompaniyets L., Bruce B.B., Yusuf H., Goodman A.B., et al. Late Conditions Diagnosed 1&#x2013;4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March&#x2013;30 June 2020. Clin. Infect. Dis. 2021;73:S5&#x2013;S16. doi: 10.1093/cid/ciab338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab338</ArticleId><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J., Wekenborg M.K., Reichert J., Kirsten C., Kahre E., Haag L., Schumm L., Czyborra P., Berner R., Armann J.P. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci. Rep. 2022;12:2246. doi: 10.1038/s41598-022-06166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J., Havdal L.B., Drevvatne M., Brodwall E.M., Berven L.L., Stiansen-Sonerud T., Einvik G., Leegaard T.M., Tjade T., Michelsen A.E., et al. Prevalence and Characteristics Associated with Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Netw. Open. 2023;6:e235763. doi: 10.1001/jamanetworkopen.2023.5763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorg A.-L., Becht S., Jank M., Armann J., von Both U., Hufnagel M., Lander F., Liese J.G., Niehues T., Verjans E., et al. Association of SARS-CoV-2 Seropositivity with Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany. JAMA Netw. Open. 2022;5:e2233454. doi: 10.1001/jamanetworkopen.2022.33454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33454</ArticleId><ArticleId IdType="pmc">PMC9516317</ArticleId><ArticleId IdType="pubmed">36166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child. Adolesc. Health. 2022;6:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kl&#xe4;ser K., Kerfoot E., Chen L., et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child. Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuta T., Aizawa Y., Shoji K., Shimizu N., Okada K., Nakano T., Kamiya H., Amo K., Ishiwada N., Iwata S., et al. Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan. Pediatr. Infect. Dis. J. 2023;42:240&#x2013;246. doi: 10.1097/INF.0000000000003792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003792</ArticleId><ArticleId IdType="pmc">PMC9935236</ArticleId><ArticleId IdType="pubmed">36730047</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Kuppermann N., Florin T.A., Tancredi D.J., Xie J., Kim K., Finkelstein Y., Neuman M.I., Salvadori M.I., Yock-Corrales A., et al. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw. Open. 2022;5:e2223253. doi: 10.1001/jamanetworkopen.2022.23253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Baptista de Lima J., Salazar L., Fernandes A., Teixeira C., Marques L., Afonso C. Long COVID in Children and Adolescents: A Retrospective Study in a Pediatric Cohort. Pediatr. Infect. Dis. J. 2023;42:e109&#x2013;e111. doi: 10.1097/INF.0000000000003829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003829</ArticleId><ArticleId IdType="pmc">PMC9990485</ArticleId><ArticleId IdType="pubmed">36728643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn B., Choi S.H., Yun K.W. Non-neuropsychiatric Long COVID Symptoms in Children Visiting a Pediatric Infectious Disease Clinic After an Omicron Surge. Pediatr. Infect. Dis. J. 2023;42:e143&#x2013;e145. doi: 10.1097/INF.0000000000003862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003862</ArticleId><ArticleId IdType="pmc">PMC10097469</ArticleId><ArticleId IdType="pubmed">36795575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Li X., Nie J., Tang K., Bhutta Z.A. A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population. Pediatrics. 2023;152:e2022060351. doi: 10.1542/peds.2022-060351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060351</ArticleId><ArticleId IdType="pmc">PMC10389775</ArticleId><ArticleId IdType="pubmed">37476923</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., Pazukhina E., Ricchiuto A., Sinatti D., Zona M., De Matteis A., D&#x2019;ilario F., Gentili C., Lanni R., et al. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol. Front. Pediatr. 2022;10:834875. doi: 10.3389/fped.2022.834875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pmc">PMC9070551</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Johnson M., Torres C. Pediatric Post-Acute Sequelae of SARS-CoV-2 infection. Fatigue Biomed. Health Behav. 2023;11:55&#x2013;65. doi: 10.1080/21641846.2022.2162764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2162764</ArticleId><ArticleId IdType="pmc">PMC10691585</ArticleId><ArticleId IdType="pubmed">38044956</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., Lepra M., Kish S.J., Rusjan P.M., Nasser Z., Verhoeff N., Vasdev N., Bagby M., Boileau I., Husain M.I., et al. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms. JAMA Psychiatry. 2023;80:787&#x2013;795. doi: 10.1001/jamapsychiatry.2023.1321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Hekmatikar A.H., Ferreira J&#xfa;nior J.B., Shahrbanian S., Suzuki K. Functional and Psychological Changes after Exercise Training in Post-COVID-19 Patients Discharged from the Hospital: A PRISMA-Compliant Systematic Review. Int. J. Environ. Res. Public Health. 2022;19:2290. doi: 10.3390/ijerph19042290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19042290</ArticleId><ArticleId IdType="pmc">PMC8871540</ArticleId><ArticleId IdType="pubmed">35206483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuut T.A., M&#xfc;ller F., Csorba I., Braamse A., Aldenkamp A., Appelman B., Assmann-Schuilwerve E., E Geerlings S., Gibney K.B., A A Kanaan R., et al. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clin. Infect. Dis. 2023;77:687&#x2013;695. doi: 10.1093/cid/ciad257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad257</ArticleId><ArticleId IdType="pmc">PMC10495128</ArticleId><ArticleId IdType="pubmed">37155736</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L., Brurberg K.G., Odgaard-Jensen J., Price J.R. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst. Rev. 2017;4:Cd003200. doi: 10.1002/14651858.CD003200.pub7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003200.pub7</ArticleId><ArticleId IdType="pmc">PMC6419524</ArticleId><ArticleId IdType="pubmed">28444695</ArticleId></ArticleIdList></Reference><Reference><Citation>Stulemeijer M., de Jong L.W.A.M., Fiselier T.J.W., Hoogveld S.W.B., Bleijenberg G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: Randomised controlled trial. BMJ. 2004;330:14. doi: 10.1136/bmj.38301.587106.63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38301.587106.63</ArticleId><ArticleId IdType="pmc">PMC539840</ArticleId><ArticleId IdType="pubmed">15585538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T., Deary V., Husain K., Walwyn R. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: A randomized controlled treatment trial. Psychol. Med. 2010;40:1269&#x2013;1279. doi: 10.1017/S003329170999153X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329170999153X</ArticleId><ArticleId IdType="pubmed">19891804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof S.L., Bleijenberg G., Uiterwaal C.S., Kimpen J.L., van de Putte E.M. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): A randomised controlled trial. Lancet. 2012;379:1412&#x2013;1418. doi: 10.1016/S0140-6736(12)60025-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60025-7</ArticleId><ArticleId IdType="pubmed">22385683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof S.L., Priesterbach L.P., Uiterwaal C.S.P.M., Bleijenberg G., Kimpen J.L.L., van de Putte E.M. Internet-based therapy for adolescents with chronic fatigue syndrome: Long-term follow-up. Pediatrics. 2013;131:e1788&#x2013;e1795. doi: 10.1542/peds.2012-2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-2007</ArticleId><ArticleId IdType="pubmed">23669515</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse A., Nikolaus S., Wiborg J.F., Heins M., van der Meer J.W., Bleijenberg G., Tummers M., Twisk J., Knoop H. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. J. Psychosom. Res. 2017;97:45&#x2013;51. doi: 10.1016/j.jpsychores.2017.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2017.03.016</ArticleId><ArticleId IdType="pubmed">28606498</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi K.M., Chan A., Weller R.J., Mi J., Jiang P., Abrahams E., Ferris A., Krishnan U.S., Pasumarti N., Suh S., et al. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021;148:e2021051155. doi: 10.1542/peds.2021-051155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051155</ArticleId><ArticleId IdType="pubmed">34266903</ArticleId></ArticleIdList></Reference><Reference><Citation>Benvenuto S., Simonini G., Della Paolera S., Abu Rumeileh S., Mastrolia M.V., Manerba A., Chicco D., Belgrano M., Caiffa T., Cattalini M., et al. CCardiac MRI in midterm follow-up of MISC: A multicenter study. Eur. J. Pediatr. 2023;182:845&#x2013;854. doi: 10.1007/s00431-022-04748-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04748-6</ArticleId><ArticleId IdType="pmc">PMC9734924</ArticleId><ArticleId IdType="pubmed">36484863</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster G., Patel A.B., Carr M.R., Rigsby C.K., Rychlik K., Rowley A.H., Robinson J.D. Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: A prospective study. J. Cardiovasc. Magn. Reson. 2021;23:86. doi: 10.1186/s12968-021-00786-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00786-5</ArticleId><ArticleId IdType="pmc">PMC8245157</ArticleId><ArticleId IdType="pubmed">34193197</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong D.T., Trachtenberg F.L., Pearson G.D., Dionne A., Elias M.D., Friedman K., Hayes K.H., Mahony L., McCrindle B.W., Oster M.E., et al. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives. Am. Heart J. 2022;243:43&#x2013;53. doi: 10.1016/j.ahj.2021.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2021.08.003</ArticleId><ArticleId IdType="pmc">PMC8710361</ArticleId><ArticleId IdType="pubmed">34418362</ArticleId></ArticleIdList></Reference><Reference><Citation>Klocperk A., Bloomfield M., Parackova Z., Aillot L., Fremuth J., Sasek L., David J., Fencl F., Skotnicova A., Rejlova K., et al. B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) Mol. Cell Pediatr. 2023;10:15. doi: 10.1186/s40348-023-00169-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40348-023-00169-z</ArticleId><ArticleId IdType="pmc">PMC10611647</ArticleId><ArticleId IdType="pubmed">37891416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>